IGLS expands its ISO 15189 accredited services
Introduction
The clinical testing services provided by Integrated Genetic Lab Services, S.L. (IGLS) play a crucial role in the field of genetics and reproductive immunology. Adhering to high standards of quality and reliability in the development of these tests is paramount. To achieve this, IGLS operates a comprehensive quality system under the UNE-EN-ISO 15189 standard, supported by its accreditation (1497/LE2766) granted by ENAC, which has recently been expanded.
The Importance of ISO Accreditation
Obtaining accreditation under ISO 15189 is no easy task. It requires a thorough and meticulous review by independent specialists who demand a high level of technical competence, review of operational procedures, intercomparison of results, and strong management capabilities. IGLS has demonstrated excellence in all these areas, resulting in a satisfactory outcome in maintaining, as well as expanding the scope of the accreditation.
This accreditation not only validates the technical expertise of IGLS but also the robustness of its operational procedures and management capabilities. Additionally, the flexibility achieved with the expansion involves a mechanism defined by ENAC, allowing accredited laboratories to make changes in methodology and other parameters, under certain conditions, without requiring prior evaluation by ENAC.
In other words, the accreditation is a testament to IGLS’s capability to provide clinical testing services at the highest level.
IGLS Clinical Tests
IGLS offers a variety of accredited clinical services (link to scope). Each of these tests is performed with technical precision and meticulous attention to detail, factors essential for ensuring quality and reliability.
From genetic tests to detect possible hereditary disorders to microbiological studies involved in reproductive processes, IGLS provides diagnostic services that help healthcare professionals make informed decisions, leading to improved patient care quality.
IGLS’s Commitment to Excellence
IGLS’s commitment to excellence goes beyond its technical credentials and ISO 15189 accreditation, which includes several of its diagnostic services. It represents a commitment to patients and healthcare professionals, ensuring they receive the most accurate and relevant information possible. IGLS continues to strive for improvement and to expand its accredited services, with a constant focus on scientific rigour and patient care.
Conclusion:
In the realm of genetics and reproductive immunology, precision and reliability are vital. Quality control and assurance in clinical diagnostic laboratories, seen as a transversal tool for prevention and health promotion, aim to protect patients by providing information used in clinical decision-making, improving diagnoses, and minimising risks. The clinical services provided by IGLS within the scope of ISO 15189 accreditation offer both qualities, providing peace of mind to patients and confidence to healthcare professionals. Given that reproductive genetics is a highly complex and constantly evolving field, these qualities are essential.